Abstract
There has been no established treatment of sudden deafness. We studied the efficacy of Dextran Dextran in the treatment of idiopathic sudden hearing loss in 32 patients who were categorized into two groups Dextran used in group A (20 cases) and Dextran was not used in group B (12 cases). The results of our study showed that as high recovery rate as 90% was obtained from either group. But complete healing rate in group A was as low as 30%, lower than the spontaneous recovery rate 32% to 55%. In conclusion, Dextran was not cunsidered to be useful in the treatment of sudden deafness.
